FISHER & PAYKEL HEAL

FPH

End-of-day quote - 01/15
31.64NZD	-1.98%

Prev.	32.2800
Open	32.3500
High	32.7500
Low	31.6400
Volume	413 143

12/22	Australia shares fall as new virus strain clouds recovery hopes
12/13	Fisher & Paykel Healthcare : wins Zenith Award from the American Association...
12/11	Australia shares fall on COVID-19 vaccine production halt, post sixth weekly...
12/06	Fisher & Paykel Healthcare : named Company of the Year and Lewis Gradon...

	Short Term	Mid-Term	Long Term
Trend	Bearish	Neutral	Bullish
Resistance	32,8	37,7	37,7
Spread/Res.	-3,7%	-16%	-16%
Spread/Supp.	1,4%	1,4%	8,4%
Support	31,2	31,2	29,2

Sales 2021	1 807 M 1 288 M 1 288 M
Net income 2021	444 M 317 M 317 M
Net cash 2021	92,1 M 65,7 M 65,7 M
P/E ratio 2021	41,0x
Yield 2021	1,22%

Capitalization	18 226 M 13 024 M 12 994 M
EV / Sales 2021	10,0x
EV / Sales 2022	10,7x
Nbr of Employees	4 731
Free-Float	99,6%

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Companyâ€™s segment includes North America, which includes all activities...

>> Read more

Sector :

Medical Equipment, Supplies & Distribution - NEC

Calendar :

2021-05-21 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	UNDERPERFORM
Number of Analysts	9
Average target price	30,45 NZD
Last Close Price	31,64 NZD
Spread / Highest target	20,7%
Spread / Average Target	-3,75%
Spread / Lowest Target	-32,5%